Pliant Therapeutics's total assets for Q1 2025 were $344.77M, a decrease of -13.15% from the previous quarter. PLRX total liabilities were $87.61M for the fiscal quarter, a -5.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.